March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :
- ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
- IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
- PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
- NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
- COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
- TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS
(([email protected];;))
March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) : ALA-101...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.003(4.39%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.7¢ | 5.4¢ | $703.3K | 12.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 2022828 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1534562 | 9 |
View Market Depth
| Last trade - 14.09pm 01/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |